This resource has been compiled by editors who are professors researching factors that compromise the total healing of body and mind in this patient population. It covers the memory problems and cognitive deficits experienced by some chemotherapy patients.
ROBERT B. RAFFA, PhD, is Professor of Pharmacology and Chair of the Department of Pharmaceutical Sciences at Temple University School of Pharmacy in Philadelphia, Pennslyvania. He holds B Chem E and BS degrees in Chemical Engineering and Physiological Psychology, MS degrees in Biomedical Engineering and Toxicology, and a PhD in Pharmacology. He is the co-author or editor of several books on pharmacology and thermodynamics and over 200 articles in refereed journals, and is active in NIH-funded research, editorial, and professional society activities. Dr. Raffa became co-founder and president of the Forget-Me-Not Foundation in 2009. RONALD J. TALLAR IDA, PhD, is a Professor of Pharmacology at Temple University School of Medicine. He has BS and MS degrees in physics/mathematics from Drexel University and a PhD in pharmacology. His work, primarily concerned with quantitative aspects of pharmacology, is represented in more than 250 published works that include eight books he has authored or co-authored. Dr. Tallarida currently teaches, serves on editorial advisory boards, conducts NIH-funded research, and is active in professional societies. Dr. Tallarida became co-founder and Vice-president of the Forget-Me-Not Foundation in 2009.
"Sobre este título" puede pertenecer a otra edición de este libro.
Gastos de envío:
EUR 2,36
A Estados Unidos de America
Gastos de envío:
GRATIS
A Estados Unidos de America
Librería: booksXpress, Bayonne, NJ, Estados Unidos de America
Soft Cover. Condición: NEW. Nº de ref. del artículo: 9781493940998
Cantidad disponible: 10 disponibles
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Condición: NEW. Nº de ref. del artículo: 30333395-n
Cantidad disponible: 5 disponibles
Librería: Lucky's Textbooks, Dallas, TX, Estados Unidos de America
Condición: NEW. Nº de ref. del artículo: ABLIING23Mar2716030186062
Cantidad disponible: Más de 20 disponibles
Librería: Ria Christie Collections, Uxbridge, Reino Unido
Condición: NEW. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Nº de ref. del artículo: ria9781493940998_lsuk
Cantidad disponible: Más de 20 disponibles
Librería: GreatBookPricesUK, Castle Donington, DERBY, Reino Unido
Condición: NEW. Nº de ref. del artículo: 30333395-n
Cantidad disponible: 5 disponibles
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
Taschenbuch. Condición: NEW. This item is printed on demand - it takes 3-4 days longer - Neuware -Cancer patients have benefitted greatly from recent advances in the drugs, dose regimens, and combinations used to treat their primary tumor and for the treatment or prevention of spread of their disease. Due to the advances in chemotherapy and other aspects of prevention, early detection, and treatment modalities, an increasing percentage of patients are surviving the disease. For some types of cancer, the majority of patients live decades beyond their diagnosis. For this they are forever thankful and appreciative of the drugs that helped lead to this increased survival rate. But no drug is devoid of adverse effects. This also applies to chemotherapeutic agents. The acute cytotoxic effects of these agents are well known--indeed are often required for their therapeutic benefit. The chronic adverse effects are varied and in some cases less well known. With the increase in survival rates, there has emerged a new awareness of these chronic adverse effects. 240 pp. Englisch. Nº de ref. del artículo: 9781493940998
Cantidad disponible: 2 disponibles
Cantidad disponible: Más de 20 disponibles
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Condición: USED_ASNEW. Unread book in perfect condition. Nº de ref. del artículo: 30333395
Cantidad disponible: 5 disponibles
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Taschenbuch. Condición: NEW. Druck auf Anfrage Neuware - Printed after ordering - Cancer patients have benefitted greatly from recent advances in the drugs, dose regimens, and combinations used to treat their primary tumor and for the treatment or prevention of spread of their disease. Due to the advances in chemotherapy and other aspects of prevention, early detection, and treatment modalities, an increasing percentage of patients are surviving the disease. For some types of cancer, the majority of patients live decades beyond their diagnosis. For this they are forever thankful and appreciative of the drugs that helped lead to this increased survival rate. But no drug is devoid of adverse effects. This also applies to chemotherapeutic agents. The acute cytotoxic effects of these agents are well known--indeed are often required for their therapeutic benefit. The chronic adverse effects are varied and in some cases less well known. With the increase in survival rates, there has emerged a new awareness of these chronic adverse effects. Nº de ref. del artículo: 9781493940998
Cantidad disponible: 1 disponibles
Librería: GreatBookPricesUK, Castle Donington, DERBY, Reino Unido
Condición: USED_ASNEW. Unread book in perfect condition. Nº de ref. del artículo: 30333395
Cantidad disponible: 5 disponibles